Stay updated on Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page.

Latest updates to the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedAdded Revision: v3.4.2 tag; removed the prior funding/operating-status notice and Revision: v3.4.1.SummaryDifference0.4%

- Check26 days agoChange DetectedSite-wide notice about funding and data currency has been added, indicating the NIH Clinical Center is open and where to find operating status updates. The page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

- Check33 days agoChange DetectedThe page now includes a glossary toggle and new headers 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0' along with 'No FEAR Act Data'. The previous labels 'Last Update Submitted that met QC Criteria', 'No FEAR Act data', and 'Revision: v3.3.4' were removed.SummaryDifference0.2%

- Check47 days agoChange DetectedRevision: v3.3.4 was added and Revision: v3.3.3 was removed. This represents a minor site-version update and does not alter the study details, eligibility criteria, or user interactions.SummaryDifference0.1%

- Check68 days agoChange DetectedUpdated the study's Locations information: a new Locations section is added and lists Kentucky, Minnesota, Missouri, and Nebraska. The previously separate state location entries (Kentucky Locations, Minnesota Locations, Missouri Locations, Nebraska Locations) have been removed in the new revision (v3.3.3).SummaryDifference0.5%

- Check97 days agoChange DetectedThe page shows a revision update from v3.2.0 to v3.3.2; no substantive content changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Nab-paclitaxel in NSCLC Clinical Trial page.